AzTrials
AzTrials

ObesityNCT02296034

Blood Glucose Variability in Obese Youth Participating in a Lifestyle Modification Program

An observational study of Obesity, run by Yale University.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to measure blood glucose variation in youth prior to and after participation in a healthy lifestyle intervention program. The hypothesis is that youth with more severe obesity and those further along in puberty will have more glycemic variability, and that glycemic variability will be… Read more about this study

Who is it for?
Ages 7 to 16 years
Conditions the study is for
Obesity
How many people
0 participants
Where
No sites listed yet
Study dates
Sep 2015to Mar 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Obese children participating in the Bright Bodies lifestyle intervention program

Who may be able to join

  • Obese (BMI >95 percentile for age based on CDC growth charts)
  • Willing to wear a CGM initially before and after the Bright Bodies program
  • Willing to check fingersticks 3 times a day while wearing the CGM
  • Willing to keep a food record before and after the Bright Bodies program
  • Be in good general health without other acute or chronic illness that in the judgment of the investigator could interfere with the study or jeopardize subject safety
  • Able to give consent (permission from parents and subject assent will be required)
  • Female subjects of reproductive potential must be abstinent or consistently using appropriate family planning methods

Who cannot join

  • Presence of any medical or psychiatric disorder that may interfere with subject safety or study conduct
  • Prior participation in the Bright Bodies program.
  • Diagnosis of diabetes
  • Participation in a concurrent lifestyle modification (exercise/nutrition) program
  • Use of any medications known to effect blood glucose levels, including oral or other systemic glucocorticoid therapy
  • Subjects using herbal supplements will be excluded, due to the unknown effects of these supplements on glucose control
Show all 9Show fewer
  • Female subjects who are pregnant, lactating, or unwilling to be tested for pregnancy
  • Subjects and/or parents who are not proficient in speaking/understanding the English language
  • Subjects who discontinue participation in the Bright Bodies program during the study period will be excluded from follow-up monitoring

About this study

The purpose of this study is to measure blood glucose variation in youth prior to and after participation in a healthy lifestyle intervention program. The hypothesis is that youth with more severe obesity and those further along in puberty will have more glycemic variability, and that glycemic variability will be improved by participation in the lifestyle intervention program.

Read the detailed description

Healthy lifestyle intervention programs aim to increase exercise and teach youth and about healthier dietary options, in hopes of avoiding obesity complications such as diabetes, and addressing the root causes of obesity. The program entitled Bright Bodies: A Lifestyle Intervention Program for Obese Youth, has been tested rigorously, showing significant improvements in body mass index and insulin resistance at both 1 and 2 years after the program and reversal of early abnormalities in glucose metabolism. While abnormalities on standardized oral glucose tolerance testing are well described in obese youth, this test may not reflect the "real life" glycemia changes in obese children. Understanding early glycemic changes in obese youth is important to better identify those at risk and strategize effective treatment plans, to avoid progression to prediabetes and diabetes. Thus the use of a continuous glucose monitor (CGM) may be a helpful adjunct to understanding the disease and therapy approaches in these patients.

A CGM is a device inserted under the skin on the abdomen which monitors glucose levels every 5 minutes, recording this information. CGM is commonly worn by kids with type 1 diabetes. The study will allow collection of information on glucose variability in much greater detail than can be seen from intermittent fingerstick glucose values or from an oral glucose tolerance test. Given the widespread epidemic of obesity and its complications, the ability to illustrate glycemic variability in obese youth is key to delineating risk categories and optimizing treatment. While lifestyle modification programs can be effective in improving measures of insulin sensitivity and OGTT results, their effect on real life glucose values has not been described. Hence the current study, aims to describe day-to-day glycemic variation in obese youth using CGM.

All enrolled subjects will wear a CGM for up to 7 days prior to initiation of the Bright Bodies program, and for up to 7 days at the end of the program. Additionally subjects will complete a food record and report exercise during both study periods. The study periods will take place during the 2 months prior to and the 2 months after completing the Bright Bodies program. The study will be explained to volunteers who meet eligibility criteria and informed consent/assent will be obtained. Demographic data will be recorded. Medical history will be obtained and a brief physical exam may be performed. Height, weight, BMI, percent body fat, fat mass, and fat free mass will be measured.

After enrollment subjects will meet with study personnel and learn how to keep a food record, with intermittent phone contact by study personnel to optimize food record compliance. They will also be asked to record exercise and any medications taken. A blinded CGM will be inserted at the beginning of each study period. Subjects will be educated regarding the CGM, including the requirement to measure blood glucose levels with a glucometer 3 times a day, at least every 12 hours (ideally on waking in the morning before eating, before dinner, and before bedtime), to calibrate the sensor. Subjects will be given a glucometer to obtain fingerstick blood sugar values and receive instruction regarding its use.

During the follow up visits the CGM will be removed, and the CGM and glucometer will be downloaded and collected. The food record will be collected.

Conditions
Obesity
Medical subject headings
Obesity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in blood glucose pre and post meal

    Change in blood glucose from meal time to 2-4 hours afterwards, before and after Bright Bodies program

    Measured: 4 months

Secondary outcomes (3)
  1. Change in mean number of calories consumed

    Change in mean number of calories consumed before and after Bright Bodies program

    Measured: 4 months

  2. Change in Glucose exposure

    Change in glucose exposure as measured by the area under the curve before and after Bright Bodies program

    Measured: 4 months

  3. Change in food consumption breakdown

    Change in the percent of kcals from total fat, sugar, and protein of food consumed before and after Bright Bodies program

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2014 (estimated)
  2. Study startSep 2015
  3. Primary completionSep 2015
  4. Study completionMar 2016

Why it stopped: Unable to recruit participants

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02296034
Sponsor's protocol ID
1409014604
Other IDs
K12DK094714
Status last verified
Mar 2020
First submitted
7 Nov 2014
Last updated
9 Mar 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity, run by Yale University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 9 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in blood glucose pre and post meal (time frame: 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2020; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in